Platinum Chromium Coronary Stent System

Bare Metal Stent Clinical Data

Not every patient is a candidate for drug eluting stents. For those who need a bare metal option, the REBEL Stent is a clear choice. In recent bare metal stent data, the Platinum Chromium (PtCr) BMS in the OMEGA Trial had 7.4% TLR. Previous BMS data on older platforms showed higher TLR rates.
REBEL bare metal stent clinical Data

OMEGA Trial*

  • A prospective, single-arm, multi-center trial
  • De novo lesions ≤ 28 mm in length and ≥ 2.25 mm to ≤ 4.50 mm in diameter
  • Primary endpoint: Target Lesion Failure (TLF) at 9 months
  • Analysis: Primary endpoint based on pre-defined performance goal of 21.2%
OMEGA Trial graphic
PtCr bare metal stent studied is the OMEGATM Platinum Chromium Coronary Stent System. Presented by John C. Wang, MD CRT 2014